Aniracetam NEW

Aniracetam is a piracetam derivative, a gamma-lactam brain function improvement agent, which can selectively act on the central nervous system and brain tissues through the blood-brain barrier, improve brain function, improve memory, and promote and enhance memory function. Compared with piracetam, it has the advantages of strong action, quick effect and low toxicity. Animal experiments have proved that this product has a good promotion effect on the memory reproduction process of normal rat discrimination learning, can fight against the memory loss caused by hypoxia, and can effectively improve the memory disorders caused by some reasons. Clinical for the treatment of senile dementia, cerebrovascular disease after memory loss and middle-aged and elderly memory loss.

Pharmacological action

Aniracetam is a cycled derivative of gamma-aminobutyric acid, which is used to improve brain function. It can selectively affect the central nervous system through the blood-brain barrier. It can activate brain cell metabolism and protect nerve cells. This product can also produce intellectual effects by affecting the glutamate receptor system. It can also improve the anti-hypoxia ability of the cortex and prevent the loss of learning and memory function caused by a variety of chemicals, hypercapnia, scopolamine or electroshock. This product has no sedative or excitatory effect, and has no vasodilator effect. Animal experiments have proved that this product has a good promotion effect on the memory reproduction process of normal rat discrimination learning, can fight against the memory loss caused by hypoxia, and can effectively improve the memory disorders caused by some reasons.

[Indication] It is clinically used to treat vascular dementia and Alzheimer's disease with mild and moderate learning, memory and cognitive dysfunction. It is also used for memory loss after stroke, benign memory impairment in middle and old age and brain retardation in children.

Adverse reaction

This product has few adverse reactions, occasionally dry mouth, anorexia, constipation, dizziness, lethargy, disappeared after withdrawal.

Matters needing attention

(1) Patients with obvious abnormal liver function should adjust the dose appropriately.

(2) This product can aggravate the symptoms of Huntington's chorea.

(3) The product is allergic to this product or to other pyrrolidone drugs do not tolerate the contrainidance.

(4) The recommended safe use range of this product is 0.3 ~ 1.8g/d.